Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST)
CUSIP: 03843E104
Q4 2021 13F Holders as of 31 Dec 2021
- Type / Class
- Equity / Common Stock, $0.001 par value
- Shares outstanding
- 120,192,308
- Total 13F shares
- 16,159,821
- Share change
- +437,269
- Total reported value
- $62,860,046
- Put/Call ratio
- 150%
- Price per share
- $3.89
- Number of holders
- 50
- Value change
- +$1,542,125
- Number of buys
- 30
- Number of sells
- 15
Quarterly Holders Quick Answers
What is CUSIP 03843E104?
CUSIP 03843E104 identifies AQST - Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 03843E104:
Top shareholders of AQST - Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Bratton Capital Management, L.P. |
13F
|
Company |
8.2%
|
9,810,958
|
$42,776,000 | — | 30 Sep 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.88%
|
1,054,304
|
$4,597,000 | — | 30 Sep 2021 | |
| Bracebridge Capital, LLC |
13F
|
Company |
0.36%
|
428,571
|
$1,869,000 | — | 30 Sep 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.28%
|
330,946
|
$1,443,000 | — | 30 Sep 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.27%
|
323,774
|
$1,412,000 | — | 30 Sep 2021 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.25%
|
297,229
|
$1,296,000 | — | 30 Sep 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.2%
|
246,048
|
$1,073,000 | — | 30 Sep 2021 | |
| Latash Investments, LLC |
13F
|
Company |
0.2%
|
243,134
|
$1,060,000 | — | 30 Sep 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.18%
|
219,640
|
$957,000 | — | 30 Sep 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.16%
|
189,669
|
$827,000 | — | 30 Sep 2021 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.15%
|
183,000
|
$798,000 | — | 30 Sep 2021 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.12%
|
148,061
|
$646,000 | — | 30 Sep 2021 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.11%
|
126,805
|
$553,000 | — | 30 Sep 2021 | |
| Brandywine Global Investment Management, LLC |
13F
|
Company |
0.1%
|
125,016
|
$545,000 | — | 30 Sep 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.1%
|
118,465
|
$517,000 | — | 30 Sep 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.1%
|
115,043
|
$502,000 | — | 30 Sep 2021 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.09%
|
104,934
|
$458,000 | — | 30 Sep 2021 | |
| IndexIQ Advisors LLC |
13F
|
Company |
0.07%
|
86,461
|
$377,000 | — | 30 Sep 2021 | |
| PDT Partners, LLC |
13F
|
Company |
0.06%
|
76,100
|
$332,000 | — | 30 Sep 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.06%
|
73,165
|
$319,000 | — | 30 Sep 2021 | |
| STATE STREET CORP |
13F
|
Company |
0.06%
|
69,877
|
$305,000 | — | 30 Sep 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.05%
|
61,274
|
$267,000 | — | 30 Sep 2021 | |
| Jump Financial, LLC |
13F
|
Company |
0.04%
|
49,700
|
$216,000 | — | 30 Sep 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.04%
|
47,300
|
$206,000 | — | 30 Sep 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.04%
|
45,729
|
$199,000 | — | 30 Sep 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.03%
|
41,711
|
$182,000 | — | 30 Sep 2021 | |
| BARCLAYS PLC |
13F
|
Company |
0.02%
|
27,926
|
$122,000 | — | 30 Sep 2021 | |
| Cresset Asset Management, LLC |
13F
|
Company |
0.02%
|
25,000
|
$109,000 | — | 30 Sep 2021 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.02%
|
21,720
|
$96,000 | — | 30 Sep 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.02%
|
21,164
|
$93,000 | — | 30 Sep 2021 | |
| Financial Advocates Investment Management |
13F
|
Company |
0.01%
|
17,000
|
$74,000 | — | 30 Sep 2021 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.01%
|
15,831
|
$69,000 | — | 30 Sep 2021 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
10,000
|
$44,000 | — | 30 Sep 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
7,557
|
$33,000 | — | 30 Sep 2021 | |
| James S. Scibetta |
3/4/5
|
Director |
—
mixed-class rows
|
51,635
mixed-class rows
|
$25,624 | — | 15 Jun 2021 | |
| Rockefeller Capital Management L.P. |
13F
|
Company |
0%
|
3,166
|
$13,000 | — | 30 Sep 2021 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
2,600
|
$11,000 | — | 30 Sep 2021 | |
| Migdal Insurance & Financial Holdings Ltd. |
13F
|
Company |
0%
|
2,406
|
$10,000 | — | 30 Sep 2021 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
2,000
|
$9,000 | — | 30 Sep 2021 | |
| FIRST MANHATTAN CO. LLC. |
13F
|
Company |
0%
|
2,000
|
$8,000 | — | 30 Sep 2021 | |
| Quantbot Technologies LP |
13F
|
Company |
0%
|
1,400
|
$6,000 | — | 30 Sep 2021 | |
| Cutler Group LLC / CA |
13F
|
Company |
0%
|
300
|
$1,000 | — | 30 Sep 2021 | |
| HARBOUR INVESTMENTS, INC. |
13F
|
Company |
0%
|
225
|
$1,000 | — | 30 Sep 2021 | |
| NEXT Financial Group, Inc |
13F
|
Company |
0%
|
200
|
$1,000 | — | 30 Sep 2021 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
117
|
$510 | — | 30 Sep 2021 | |
| Nancy Lurker |
3/4/5
|
Director |
—
class O/S missing
|
20,000
|
— | — | 15 Jun 2021 |
Institutional Holders of Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST) as of Q4 2021
As of 31 Dec 2021,
Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST) was held by
50 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,159,821 shares.
The largest 10 holders included
Bratton Capital Management, L.P., VANGUARD GROUP INC, Vahanian & Associates Financial Planning Inc., Bracebridge Capital, LLC, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, Latash Investments, LLC, MORGAN STANLEY, and BRIDGEWAY CAPITAL MANAGEMENT, LLC.
This page lists
50
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
44
Q4 2021 holders
50
Holder diff
6
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.